MCAB awaits chair appointment for final decision on recommended conditions

On Aug 13, 2024

During the last few months, the Illinois Department of Public Health (IDPH), in conjunction with the Medical Cannabis Advisory Board (MCAB), voted to add four new recommended conditions to list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. The recommendations have been on hold, including postponing the July board meeting, until the Office of the Governor appoints a chair and co-chair to the board.

For this annual process, MCAB has voted to recommend four new conditions, including Endometriosis, Female Organismic Disorder, Ovarian Cyst, and Uterine Fibroid. Separate votes for a “qualifying term” to the condition also was recommended for Painful Ovarian Cyst and Painful Uterine Fibroid. The four recommend conditions have been forwarded to the IDPH Director’s office for final decision and are awaiting the appointment of a MCAB chair and co-chair. Neither an appointment date nor a date for the next MCAB meeting has been set.

“The governor’s office is working to finalize the appointment of a chair and co-chair for the board, and we are working to schedule its next meeting,” said Public Information Officer, Jim Leach. “At its last meeting, the board offered recommendations on the potential inclusion of additional conditions to be eligible for medical cannabis. Those recommendations are being reviewed by the IDPH director’s office.”

The votes for Generalized Anxiety and Polycystic Ovarian Syndrome fell short and were not recommended. Generalized Anxiety and Polycystic Ovarian Syndrome may be reintroduced during the next annual process in order to revisit a vote. For more Illinois cannabis industry news, subscribe to Illinois News Joint’s newsletter here.

To find cannabis-friendly events in Illinois, visit here.

For Illinois News Joint reviews, visit here.

For more information on News Joint Bar Service, visit here.

For News Joint Printing services, click here.

Currently, qualifying patients must be diagnosed with a debilitating condition to be eligible for a medical cannabis registry identification card in Illinois. Conditions include:

Autism
Agitation of Alzheimer’s disease
HIV/AIDS
Amyotrophic lateral sclerosis (ALS)
Anorexia nervosa
Arnold-Chiari malformation
Cancer
Cachexia/wasting syndrome
Causalgia
Chronic inflammatory demyelinating polyneuropathy
Chronic pain
Crohn’s disease
CRPS (complex regional pain syndrome Type II)
Dystonia
Ehlers-Danlos syndrome
Fibrous Dysplasia
Glaucoma
Hepatitis C
Hydrocephalus
Hydromyelia
Interstitial cystitis
Irritable bowel syndrome
Lupus
Migraines
Multiple Sclerosis
Muscular Dystrophy
Myasthenia Gravis
Myoclonus
Nail-patella syndrome
Neuro-Bechet’s autoimmune disease
Neurofibromatosis
Neuropathy
Osteoarthritis
Parkinson’s disease
Polycystic kidney disease (PKD)
Post-Concussion Syndrome
Post-Traumatic Stress Disorder (PTSD)
Reflex sympathetic dystrophy
Residual limb pain
Rheumatoid arthritis
Seizures (including those characteristic of Epilepsy)
Severe fibromyalgia
Sjogren’s syndrome
Spinal cord disease (including but not limited to arachnoiditis)
Spinal cord injury is damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity
Spinocerebellar ataxia
Superior canal dehiscence syndrome
Syringomyelia
Tarlov cysts
Tourette syndrome
Traumatic brain injury
Ulcerative colitis

Last updated August 15, 2019

Source link